Delivery Order SPE2DB22D2005-SPE2DB23FJSC8
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,184 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 22, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued against an unspecified government-wide acquisition...
- The Defense Logistics Agency awarded a $63,391 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under an existing DLA-wide supply contract vehicle...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,848 to Amerisourcebergen Drug Corporation to supply 30 units of Restasis 0.05% eye emulsion. As the prime contractor, Amerisourcebergen Drug Corporation will perform under the contract from its facility in Conshohocken, Pennsylvania. The order is funded through the Defense Logistics Agency and supports the agency's medical supply needs. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,952 to Amerisourcebergen Drug Corporation for the supply of 60 units of Restasis 0.05% eye emulsion. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 13, 2023 under the terms of the order. Amerisourcebergen Corporation is the identified parent company of the prime contractor. No major...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $20,242.29 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order for the emulsion to support the Defense Logistics Agency's medical supply needs. No subcontractors or set...
- The Defense Logistics Agency awarded a $6,733 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. Under this firm fixed price contract, Amerisourcebergen will provide 30 units of the eye medication to a location in Conshohocken, Pennsylvania by August 10, 2023. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen frequently supports the Defense Logistics Agency's mission to provide materials to the U.S. military through contracts like...
- The Defense Logistics Agency awarded a $4,690.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561543515 RESTASIS 0.05% eye emulsion. The delivery order was issued against an existing DLA contract vehicle and calls for the delivery of 30 units of the specified ophthalmic product to a facility in Conshohocken, Pennsylvania. Performance is required from July 19-20, 2023. Amerisourcebergen Corporation is the identified parent company of Amerisourcebergen...
- The Defense Logistics Agency awarded a $2,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by August 22, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen frequently supports the Defense Logistics Agency's mission to provide materials to all branches...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,292 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order is to provide sixty units of the product with performance taking place in Conshohocken, Pennsylvania over a period of three days from August 18 through August 21, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime...
- The Defense Logistics Agency awarded a $16,586 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract spanning August 18 through 21, 2023. No subcontractors or set aside designations were identified. DLA manages the global supply...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB23FJSC8Delivery Order
The Defense Logistics Agency awarded a $3,988 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will deliver 30 units of the prescribed ophthalmic solution to a facility in Conshohocken, Pennsylvania by July 27, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform the contract through its corporate office division. No subcontractors or set aside designations were identified. The order is a small purchase aligned with DLA's mission to provide medical supplies and services to military treatment facilities worldwide.
Generated 12/14/23, 5:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/26/23 |